merck results beat expectations as top drugs keytruda, gardasil post strong sales
Published 9 months ago • 506 plays • Length 0:26Download video MP4
Download video MP3
Similar videos
-
0:39
merck beats earnings expectations, raises sales outlook on strong demand for top drugs like keytruda
-
0:36
merck tops earnings estimates on strong demand for keytruda even as hpv vaccine sales fall
-
1:13
merck beats earnings expectations, raises outlook on strong keytruda and vaccine sales
-
2:50
merck earnings beat on top and bottom lines, raises forecast
-
1:51
merck beats q3 earnings and revenue expectations
-
5:53
merck ceo on winrevair approval, obesity drug, health costs
-
5:41
merck ceo on covid pill distribution, vaccine development
-
1:55
merck vaccines
-
6:07
merck ceo rob davis on q2 results: we continue to see phenomenal growth
-
2:41
merck, pfizer post earnings beats
-
2:34
pfizer, merck both post earnings beats
-
0:55
merck covid pill reduces death and hospitalization risk by 30%: study
-
4:39
what merck's treatment means for the company, vaccine makers
-
6:45
dr. anthony fauci: merck anti-viral covid drug is an 'important advance'
-
3:53
merck reduced prices of small and insignificant drugs: analyst
-
3:11
evercore rates merck as outperform while the company tests anti-viral covid therapies
-
2:01
merck stock pops on earnings beat, covid treatment sales
-
3:40
merck's covid drug is a massive potential market opportunity: guggenheim's fernandez
-
2:59
merck ceo davis provides update on highly anticipated covid-19 pill
-
3:59
covid patients now have an option: merck exec
-
5:48
dr. scott gottlieb: merck's oral covid-19 pill is a 'profound game changer'
-
3:59
what's next for merck after announcing its oral antiviral covid pill